News Detail
New Delhi, 4 Oct 2023: The Multi-Disciplinary Committee (MDC) of Experts under the National Pharmaceutical Pricing Authority (NPPA) has recommended to grant exemption to Panacea Biotec's EasyFourPoI vaccine, an adsorbed diphtheria, tetanus, pertussis, inactivated poliomyelitis, a......
View Details
Source : Pharmabiz
Multi-Disciplinary Committee
MDC
NPPA
Panacea Biotec
EasyFourPoI vaccine
diphtheria
tetanus
pertussis
inactivated poliomyelitis
haemophilus influenzae type B
conjugate vaccine
DPCO
2013
Indian Patent Act
Universal Immunisation Programme
UIP
DCGI
Para 32
Easy Six
Related News
- Indian Patent Office to hear objections on Gilead's HIV drug patent claims (18-09-2024)
- CDSCO revises guidance document for functions & responsibilities of zonal, sub-zonal & port offices (18-09-2024)
- India exported drugs and pharma worth $11.9 bn in April-August 2024 (18-09-2024)
- US FDA releases draft guidance on oncology multiregional clinical trials (18-09-2024)
- Narcotists raid in UP-Uttarakhand, fake medicines worth three crores, machines worth eight crores seized, five arrested (18-09-2024)
- DCC recommends making Sugam portal database of all products with brand names (17-09-2024)
- CDSCO releases draft guidelines on good clinical practices for consultation (17-09-2024)
- One-third of India’s 30 lakh sepsis deaths linked to antimicrobial resistance (17-09-2024)
- Pharmacist practicing without degree, 35 types of medicines and surgical equipments seized (17-09-2024)
- CDSCO to switch Form 44 submission online (16-09-2024)